FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W86436650> ?p ?o ?g. }

• W86436650 abstract "The toxicity of a specific group of chemotherapeutic drugs was demonstrated to be enhanced in the presence of non-toxic concentrations of a number of nonsteroidal anti-inflammatory drugs (NSAIDs). This was found to occur in the drug sensitive A549 human lung adenocarcinoma and D L K P human lung squamous carcinoma cell lines.The chemotherapeutic drugs for which the toxicity enhancement effect was found to occur (adriamycin, daunorubicin, epirubicin, vincristine and VP-16) share the property of being potential substrates for the multidrug resistance associated protein (MRP). The toxicity of drugs which were not MRP-substrates, was unaffected by NSAID treatment. The toxicity of non-chemotherapeutic drug substrates for MRP, such as the heavy metal sodium arsenate was also found to be enhanced in the presence of a suitable NSAID.NSAIDs are believed to exert their anti-inflammatory, analgesic and antipyretic effects in vivo as a result of their ability to inhibit the enzyme prostaglandin H 2 synthase (PGHS), which is also known as cyclooxygenase (COX). The only NSAIDs found to possess chemotherapeutic drug toxicity enhancing abilities were: indomethacin, sulindac, sulindac sulfide, sulindac sulfone, tolmetin, acemetacin, mefenamic acid and zomepirac. The mechanism by which these NSAIDs enhanced the toxicity of a suitable chemotherapeutic drug was demonstrated to be independent of any effects of NSAIDs on PGHS. This was conclusively demonstrated by the ability of sulindac sulfone (a metabolite of sulindac which is devoid of inhibitory effects on PGHS) to enhance chemotherapeutic drug toxicity to the same extent as achieved using sulindac sulfide (a metabolite of sulindac with potent inhibitory effects on PGHS).MRP protein was demonstrated by Western blotting to be present in low levels in DLKP plasma membrane-derived inside-out vesicles (10Vs). The MRP in DLKP IOVs was demonstrated to actively transport the M R P substrate leukotriene C 4 (LtC4). This transport was shown to be inhibited by NSAIDs with drug toxicity enhancing abilities such as indomethacin, but was unaffected by NSAIDs which were without influence on chemotherapeutic d m g toxicity. These results suggested that NSAID-mediated enhancement of chemotherapeutic drug toxicity was dependent on the ability of an NSAED to interfere with the drug efflux activity of MRP.The presence of M R P protein in 10 Vs facilitated investigation into the cytotoxic drug transporting characteristics of MRP. The LtC4 transport activity of MRP in IOVs from the MRP-overexpressing cell line H L 6 0 - A D R was found to be significantly inhibited by vincristine (an MRP substrate) but not by Taxol or cisplatin (non-MRP substrates). This inhibition in LtC4 transport with vincristine was synergistically enhanced in the presence of non-inhibitory concentrations of reduced glutathione (GSH). These results suggested that M R P substrate drugs such as vincristine may be actively transported by M R P in the presence of GSH.Demonstration of the presence of active MRP protein in DLKP suggested that M R P may also have been present in resistant variants of DLKP. Active MRP protein was shown to be present in a variety of DLKP-related drug resistant cell lines namely DLKP-A10, DLKPA2B, DLKPA 1 IB, DLKPA 6 B and DLKPA5F. Preliminary evidence suggested that MRP may be involved in certain aspects of the cytotoxic drug accumulation characteristics of these drug resistant variants of DLKP." @default.
• W86436650 created "2016-06-24" @default.
• W86436650 creator A5031162881 @default.
• W86436650 date "1997-01-01" @default.
• W86436650 modified "2023-09-27" @default.
• W86436650 title "Investigations on the role of efflux pumps in drug resistance of human cancer cells" @default.
• W86436650 cites W101324336 @default.
• W86436650 cites W135043852 @default.
• W86436650 cites W140981747 @default.
• W86436650 cites W1480887469 @default.
• W86436650 cites W1485234727 @default.
• W86436650 cites W1488935046 @default.
• W86436650 cites W1490609633 @default.
• W86436650 cites W1494920110 @default.
• W86436650 cites W1496152087 @default.
• W86436650 cites W1497498736 @default.
• W86436650 cites W1508319830 @default.
• W86436650 cites W1519177607 @default.
• W86436650 cites W1523034549 @default.
• W86436650 cites W1528219915 @default.
• W86436650 cites W1532556593 @default.
• W86436650 cites W1537952340 @default.
• W86436650 cites W1538763799 @default.
• W86436650 cites W1539601638 @default.
• W86436650 cites W1540429594 @default.
• W86436650 cites W1541405335 @default.
• W86436650 cites W1547685461 @default.
• W86436650 cites W1551959442 @default.
• W86436650 cites W1556429708 @default.
• W86436650 cites W1561829393 @default.
• W86436650 cites W1565651933 @default.
• W86436650 cites W1567907251 @default.
• W86436650 cites W1572770561 @default.
• W86436650 cites W1576201925 @default.
• W86436650 cites W1583427298 @default.
• W86436650 cites W1585935799 @default.
• W86436650 cites W1587945417 @default.
• W86436650 cites W1595506167 @default.
• W86436650 cites W1620132817 @default.
• W86436650 cites W1647833960 @default.
• W86436650 cites W1648335868 @default.
• W86436650 cites W1650739449 @default.
• W86436650 cites W168095317 @default.
• W86436650 cites W1681307511 @default.
• W86436650 cites W1755086614 @default.
• W86436650 cites W1768069605 @default.
• W86436650 cites W1781950500 @default.
• W86436650 cites W179145490 @default.
• W86436650 cites W180357471 @default.
• W86436650 cites W1815735775 @default.
• W86436650 cites W1816122400 @default.
• W86436650 cites W1847040016 @default.
• W86436650 cites W1847864430 @default.
• W86436650 cites W186047545 @default.
• W86436650 cites W1865550052 @default.
• W86436650 cites W1868796410 @default.
• W86436650 cites W1869980306 @default.
• W86436650 cites W1876192519 @default.
• W86436650 cites W1890023926 @default.
• W86436650 cites W1896547048 @default.
• W86436650 cites W1908952923 @default.
• W86436650 cites W1911655428 @default.
• W86436650 cites W1928411162 @default.
• W86436650 cites W1951191325 @default.
• W86436650 cites W1956702905 @default.
• W86436650 cites W1965171480 @default.
• W86436650 cites W1967004332 @default.
• W86436650 cites W1970030796 @default.
• W86436650 cites W1970900770 @default.
• W86436650 cites W1971804850 @default.
• W86436650 cites W1972562299 @default.
• W86436650 cites W1972931565 @default.
• W86436650 cites W1973097909 @default.
• W86436650 cites W1973628488 @default.
• W86436650 cites W1973907718 @default.
• W86436650 cites W1977550995 @default.
• W86436650 cites W1977686001 @default.
• W86436650 cites W1977851304 @default.
• W86436650 cites W1979773981 @default.
• W86436650 cites W1980678458 @default.
• W86436650 cites W1980798571 @default.
• W86436650 cites W1981223734 @default.
• W86436650 cites W1981267478 @default.
• W86436650 cites W1981581994 @default.
• W86436650 cites W1983662467 @default.
• W86436650 cites W1985032385 @default.
• W86436650 cites W1985600031 @default.
• W86436650 cites W1985968333 @default.
• W86436650 cites W1986439328 @default.
• W86436650 cites W1987437563 @default.
• W86436650 cites W1991925356 @default.
• W86436650 cites W1994555547 @default.
• W86436650 cites W1994818689 @default.
• W86436650 cites W1996147091 @default.
• W86436650 cites W1997863649 @default.
• W86436650 cites W1999330214 @default.
• W86436650 cites W2003448477 @default.
• W86436650 cites W2004178100 @default.
• W86436650 cites W2004293605 @default.
• W86436650 cites W2004351423 @default.

• next